Deep Track Capital, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.27 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Dynavax Technologies Corp with a value of $227M, Guardant Health, Inc. with a value of $196M, Intra Cellular Therapies, Inc. with a value of $167M, Immunovant, Inc. with a value of $165M, and Apellis Pharmaceuticals, Inc. with a value of $136M.

Examining the 13F form we can see an decrease of $442M in the current position value, from $2.71B to 2.27B.

Deep Track Capital, LP is based out at Greenwich, CT

Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $2.27 Billion
Healthcare: $2.27 Billion

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $2.27 Billion
  • Prior Value $2.71 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 14 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.